Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annarein J C Kerbert

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
F1000Research|May 14, 2020
Recent advances in understanding and managing hepatic encephalopathy in chronic liver diseaseAnnarein J C Kerbert, Rajiv Jalan
JHEP Reports : Innovation in Hepatology|July 18, 2022
Hyperammonaemia induces mitochondrial dysfunction and neuronal cell deathPlamena R Angelova, Annarein J C Kerbert, Abeba Habtesion, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 21, 2026
Albumin Restores Endothelial Cell Mitochondrial Morphology in Patients With Decompensated CirrhosisSusan E Fischer, Rudmer J Postma, Roel Bijkerk, et al.
Seminars in Liver Disease|May 15, 2021
The Current Status of Granulocyte-Colony Stimulating Factor to Treat Acute-on-Chronic Liver FailureCornelius Engelmann, Vincent Di Martino, Annarein J C Kerbert, et al.
European Journal of Gastroenterology & Hepatology|December 22, 2016
Hemodynamic response to primary prophylactic therapy with nonselective β-blockers is related to a reduction of first variceal bleeding risk in liver cirrhosis: a meta-analysisAnnarein J C Kerbert, Fang W T Chiang, Mark van der Werf, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 27, 2015
Copeptin is an independent prognostic factor for transplant-free survival in cirrhosisAnnarein J C Kerbert, Delphine Weil, Hein W Verspaget, et al.
Cardiovascular and Interventional Radiology|September 28, 2016
Differences in Patient Characteristics and Midterm Outcome Between Asian and European Patients Treated with Radiofrequency Ablation for Hepatocellular CarcinomaMark Christiaan Burgmans, Chow Wei Too, Marta Fiocco, et al.
Critical Care (London, England)|December 23, 2017
Copeptin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survivalAnnarein J C Kerbert, Hein W Verspaget, Àlex Amorós Navarro, et al.
Clinics and Research in Hepatology and Gastroenterology|June 16, 2026
Dipstick urinary chloride as a surrogate marker of urinary sodium in cirrhosis: a prospective multicenter pilot studySusan E Fischer, Britt van Ruijven, Annarein J C Kerbert, et al.
Plos One|September 18, 2015
Copeptin as an Indicator of Hemodynamic Derangement and Prognosis in Liver CirrhosisAnnarein J C Kerbert, Len Verbeke, Fang W T Chiang, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
F1000Research|May 14, 2020
Recent advances in understanding and managing hepatic encephalopathy in chronic liver diseaseAnnarein J C Kerbert, Rajiv Jalan
JHEP Reports : Innovation in Hepatology|July 18, 2022
Hyperammonaemia induces mitochondrial dysfunction and neuronal cell deathPlamena R Angelova, Annarein J C Kerbert, Abeba Habtesion, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 21, 2026
Albumin Restores Endothelial Cell Mitochondrial Morphology in Patients With Decompensated CirrhosisSusan E Fischer, Rudmer J Postma, Roel Bijkerk, et al.
Seminars in Liver Disease|May 15, 2021
The Current Status of Granulocyte-Colony Stimulating Factor to Treat Acute-on-Chronic Liver FailureCornelius Engelmann, Vincent Di Martino, Annarein J C Kerbert, et al.
European Journal of Gastroenterology & Hepatology|December 22, 2016
Hemodynamic response to primary prophylactic therapy with nonselective β-blockers is related to a reduction of first variceal bleeding risk in liver cirrhosis: a meta-analysisAnnarein J C Kerbert, Fang W T Chiang, Mark van der Werf, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 27, 2015
Copeptin is an independent prognostic factor for transplant-free survival in cirrhosisAnnarein J C Kerbert, Delphine Weil, Hein W Verspaget, et al.
Cardiovascular and Interventional Radiology|September 28, 2016
Differences in Patient Characteristics and Midterm Outcome Between Asian and European Patients Treated with Radiofrequency Ablation for Hepatocellular CarcinomaMark Christiaan Burgmans, Chow Wei Too, Marta Fiocco, et al.
Critical Care (London, England)|December 23, 2017
Copeptin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survivalAnnarein J C Kerbert, Hein W Verspaget, Àlex Amorós Navarro, et al.
Clinics and Research in Hepatology and Gastroenterology|June 16, 2026
Dipstick urinary chloride as a surrogate marker of urinary sodium in cirrhosis: a prospective multicenter pilot studySusan E Fischer, Britt van Ruijven, Annarein J C Kerbert, et al.
Plos One|September 18, 2015
Copeptin as an Indicator of Hemodynamic Derangement and Prognosis in Liver CirrhosisAnnarein J C Kerbert, Len Verbeke, Fang W T Chiang, et al.
Pageof 3